PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

PAR ASX Announcement - pure Obfuscation

  1. 75 Posts.
    lightbulb Created with Sketch. 77
    If the FDA reply was basically good news, or even neutral, PR would sure have provided some details. He didn't give us ANYTHING substantive at all or even signal anything positive which means there must be some very significant issues bothering the FDA. The announcement is pure word-smithing obfuscation.- very disappointing. Even more problematic is that PR is just not telling it like it is. IMO PR now has a real credibility problem.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.